Expression of PAX8 in Normal and Neoplastic Tissues: A Comprehensive Immunohistochemical Study
暂无分享,去创建一个
Liang Cheng | Ding Zhou | Liang Cheng | David Tacha | D. Tacha | Ding Zhou
[1] A. Hummer,et al. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis , 2006, Modern Pathology.
[2] M. Nap,et al. The value of tumour marker CA 125 in surgical pathology , 1987, Histopathology.
[3] A. Haitel,et al. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study , 2005, Modern Pathology.
[4] B. Geramizadeh,et al. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. , 2008, Indian journal of pathology & microbiology.
[5] Luis Chiriboga,et al. Expression of Pax8 as a Useful Marker in Distinguishing Ovarian Carcinomas From Mammary Carcinomas , 2008, The American journal of surgical pathology.
[6] P. Unger,et al. Expression of PAX8 in Nephrogenic Adenoma and Clear Cell Adenocarcinoma of the Lower Urinary Tract: Evidence of Related Histogenesis? , 2008, The American journal of surgical pathology.
[7] L. Norton,et al. Expression of WT1, CA 125, and GCDFP-15 as Useful Markers in the Differential Diagnosis of Primary Ovarian Carcinomas Versus Metastatic Breast Cancer to the Ovary , 2005, The American journal of surgical pathology.
[8] J. Srigley,et al. Expression Analysis of Kidney-specific Cadherin in a Wide Spectrum of Traditional and Newly Recognized Renal Epithelial Neoplasms: Diagnostic and Histogenetic Implications , 2007, The American journal of surgical pathology.
[9] C. Magi-Galluzzi,et al. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. , 2005, Clinics in laboratory medicine.
[10] M. Mansukhani,et al. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study , 2009, Modern Pathology.
[11] R. B. Thomson,et al. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. , 2005, Human pathology.
[12] Weijian Zhu,et al. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions , 2007, Diagnostic cytopathology.
[13] N. Bowen,et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. , 2007, Gynecologic oncology.
[14] S. Leung,et al. Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies , 2008, PLoS medicine.
[15] M. Rivera,et al. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms , 2008, Modern Pathology.
[16] E. Paish,et al. The expression of Wilms’ tumour‐1 and Ca125 in invasive micropapillary carcinoma of the breast , 2007, Histopathology.
[17] A. Renshaw,et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. , 2000, The American journal of surgical pathology.
[18] B. Sosa-Pineda,et al. The gene Pax4 is an essential regulator of pancreatic beta-cell development. , 2004, Molecules and cells.
[19] C. Brown,et al. Immunocytochemical and serological expression of CA 125: a clinicopathological study of 40 malignant ovarian epithelial tumours , 1994, Histopathology.